[Liver resection--indications and results]

Tidsskr Nor Laegeforen. 2001 Sep 10;121(21):2476-80.
[Article in Norwegian]

Abstract

Background: Liver resection is an established treatment for malignancies like colorectal metastases and hepatocellular carcinoma.

Material and methods: Indications and outcomes of liver resection at the National Hospital, Oslo, Norway was studied retrospectively in 226 patients operated between 1977 and 1999.

Results: The main indication for surgery was colorectal metastases (n = 137). The frequency of liver resection for colorectal malignancies was < 1 per 100,000 patients per year in the hospital's catchment area. Other indications included hepatocellular carcinoma (n = 30), benign tumours like hemangioma (n = 14), and various primary and secondary malignant tumours. Reoperation due to postoperative complications was performed in 13 patients (6%). Total perioperative mortality defined as death before hospital discharge or within 30 days after discharge, was 3% (7/226). No perioperative deaths occurred among the 159 patients operated after 1987. Five year survival for patients operated for colorectal metastases and hepatocellular carcinoma were 29% and 24%, respectively.

Interpretation: The main indication for liver resection is colorectal metastases. Liver resection is a safe operation with potential curation for selected patients.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / secondary
  • Carcinoma, Hepatocellular / surgery*
  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / secondary
  • Colorectal Neoplasms / surgery*
  • Female
  • Hepatectomy* / adverse effects
  • Hepatectomy* / methods
  • Hepatectomy* / standards
  • Humans
  • Liver Neoplasms / mortality
  • Liver Neoplasms / secondary
  • Liver Neoplasms / surgery*
  • Male
  • Medical Illustration
  • Middle Aged
  • Reoperation
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome